Skip to main content
Figure 2 | Arthritis Research & Therapy

Figure 2

From: Degradation of neutrophil extracellular traps co-varies with disease activity in patients with systemic lupus erythematosus

Figure 2

Decreased ability to degrade NETs affects 41% of the SLE patients. A-B. The ability of serum to degrade NETs compared to internal control of serum from 77 healthy controls (A) and 69 patients with SLE followed during multiple time points (B). Dashed line indicates cut-off for "normal" and "decreased" degradation. C. The fraction of all time points for which patients, who at least once displayed a decreased ability to degrade NETs, had a decreased NET degrading ability. Quantiles are displayed in gray with a median of 20% and mean of 34% (not shown). NETs, neutrophil extracellular traps; SLE, systemic lupus erythematosus

Back to article page

Arthritis Research & Therapy

ISSN: 1478-6362

Contact us